Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

Randomized Trial Comparing Bupivacaine vs Lipossomic Extended Release Bupivacaine for Postoperative Pain Control After Minimally Invasive Thoracic Surgery

Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine compared to lipossomal extended release bupivacaine.

Patients undergoing minimally invasive thoracic surgery will be randomized to receive 0.05% bupivacaine with 1:200,000 epinephrine (control group) or extended release lipossomal bupivacaine. Primary outcomes are postoperative pain measured by visual analog scale, amount of morphine equivalent narcotics used, and postoperative complications. Patients are excluded if they undergo open thoracotomy, or minimally invasive decortication.

Inclusion Criteria: Patients who will be undergoing minimally invasive thoracic surgery

• Patients who will be undergoing minimally invasive thoracic surgery

Exclusion Criteria:

• Open surgery
• Chronic use of narcotics
• Use of pregabalin or similar
• Significant liver or kidney dysfunction